Chloraprep one-step and Mycophenolate mofetil drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Chloraprep one-step (chlorhexidine gluconate; isopropyl alcohol) and Mycophenolate mofetil (mycophenolate mofetil). Common drug interactions include lower respiratory tract infection among females.
The phase IV clinical study analyzes what interactions people have when they take Chloraprep one-step and Mycophenolate mofetil. It is created by eHealthMe based on reports of 15 people who take the same drugs from the FDA, and is updated regularly.
What is Chloraprep one-step?
Chloraprep one-step has active ingredients of chlorhexidine gluconate; isopropyl alcohol. eHealthMe is studying from 582 Chloraprep one-step users. Check the latest studies of Chloraprep one-step.
What is Mycophenolate mofetil?
Mycophenolate mofetil has active ingredients of mycophenolate mofetil. It is often used in myasthenia gravis. eHealthMe is studying from 93,460 Mycophenolate mofetil users. Check the latest studies of Mycophenolate mofetil.
15 people who take Chloraprep one-step and Mycophenolate mofetil together, and have interactions are studied.

What are the common drug interactions of Chloraprep One-Step and Mycophenolate Mofetil, by gender? *:
female:
- Lower respiratory tract infection
- Abdominal pain upper
- Deep vein thrombosis postoperative (blood clot in a major vein that usually develops in the legs and/or pelvis after operation)
- Gastrointestinal disorder (functional problems of gastrointestinal tract)
- General physical health deterioration (weak health status)
- Helicobacter infection (helicobacter pylori (h. pylori) infects stomach)
- Hypoaesthesia (reduced sense of touch or sensation)
- Irritable bowel syndrome
- Musculoskeletal pain (pain affects the bones, muscles, ligaments, tendons, and nerves)
- Musculoskeletal stiffness (stiffness of the body's muscles, joints, tendons, ligaments and nerves)
male:
n/a
What are the common drug interactions of Chloraprep One-Step and Mycophenolate Mofetil, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
n/a
40-49:
- Lower respiratory tract infection
- Abdominal pain upper
- Autoimmune disorder (a condition in which the immune system attacks the body's normal substances and tissue)
- Deep vein thrombosis postoperative (blood clot in a major vein that usually develops in the legs and/or pelvis after operation)
- Gastrointestinal disorder (functional problems of gastrointestinal tract)
- General physical health deterioration (weak health status)
- Helicobacter infection (helicobacter pylori (h. pylori) infects stomach)
- Hypoaesthesia (reduced sense of touch or sensation)
- Irritable bowel syndrome
- Musculoskeletal stiffness (stiffness of the body's muscles, joints, tendons, ligaments and nerves)
50-59:
n/a
60+:
n/a
What are the existing conditions these people have? *
- Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 15 people, 100.00%
- Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 12 people, 80.00%
- Systemic Lupus Erythematosus (an autoimmune disease, which means the body's immune system mistakenly, attacks healthy tissue): 11 people, 73.33%
- Urticaria (rash of round, red welts on the skin that itch intensely): 8 people, 53.33%
- Fever: 8 people, 53.33%
- Psoriasis (immune-mediated disease that affects the skin): 7 people, 46.67%
- Arthritis (form of joint disorder that involves inflammation of one or more joints): 4 people, 26.67%
- Synovitis (inflammation of the synovial membrane): 3 people, 20.00%
- Stress And Anxiety: 3 people, 20.00%
- Pemphigus (any of several acute or chronic skin diseases characterized by groups of itching blisters): 3 people, 20.00%
* Approximation only. Some reports may have incomplete information.
Do you take Chloraprep one-step and Mycophenolate mofetil?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Chloraprep one-step (582 reports)
- Mycophenolate mofetil (93,460 reports)
Browse all drug interactions of Chloraprep one-step and Mycophenolate mofetil:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Chloraprep one-step:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Mycophenolate mofetil:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Chloraprep one-step and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Mycophenolate mofetil and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on chlorhexidine gluconate; isopropyl alcohol and mycophenolate mofetil (the active ingredients of Chloraprep one-step and Mycophenolate mofetil, respectively), and Chloraprep one-step and Mycophenolate mofetil (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Avonex and Multivitamin drug interactions for women aged 60+ - 2 seconds ago
- Oral Discomfort and drugs of ingredients of sertraline hydrochloride - 4 seconds ago
- Dulcolax and Miralax drug interactions for girls aged 10-19 - 6 seconds ago
- Niacin vs. Atorvastatin Calcium, side effect and effectiveness comparison - 9 seconds ago
- Sitagliptin and Hypokalemic Syndrome for Men aged 60+ - 11 seconds ago
- Sitagliptin and Hypokalaemic Syndrome for Men aged 60+ - 11 seconds ago
- Sitagliptin and Hypopotassemia for Men aged 60+ - 11 seconds ago
- Sitagliptin and Hypokalaemia for Men aged 60+ - 12 seconds ago
- Sitagliptin and Potassium - Low for Men aged 60+ - 12 seconds ago
- Sitagliptin and Low Blood Potassium for Men aged 60+ - 12 seconds ago